Drug Trial Radar · NCT07249905
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Apr 13, 2026
Primary completion
Jan 2028
Study completion Apr 2030
Sponsor
- Lead sponsor
- ModeX Therapeutics, An OPKO Health CompanyIndustry
- Sponsor type
- Industry
- First posted
- Nov 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2003 in patients with different types of lymphoma
Conditions
- Lymphoma
- Waldenström Macroglobulinemia (WM)
- DLBCL - Diffuse Large B Cell Lymphoma
- PMBCL
- HGBCL
- FL Lymphoma
- Lymphoplasmacytic Lymphoma
- Follicular Lymphoma (FL)
Interventions
MDX2003Drug
MDX2003 intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A only- Identify the Maximum Tolerated Dose (MTD) for expansion for further development of MDX2003Time frame: 28 days
- All Study Parts: Adverse Events (AEs)Time frame: Baseline until 90 days after the participant has the last dose of MDX2003
- Part B only- Assess the preliminary anti-lymphoma activity of MDX2003Time frame: From date of enrollment until the end of treatment, up to approximately 6 months
Locations
7 sites in 3 countries. Site status is shown where the registry gives one.
Epworth HealthCare
Richmond, Victoria, Australia · Recruiting
Linear Clinical Research
Nedlands, Western Australia, Australia · Recruiting
Rambam Medical Center
Haifa, Israel · Recruiting
Hadassah Medical Center
Jerusalem, Israel · Recruiting
Rabin Medical Center - Beilinson Hospital
Petah Tikva, Israel · Recruiting
Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel · Recruiting
Virgen del Rocío University Hospital
Seville, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.